ASH 2009 meeting report-Top 10 clinically oriented abstracts in lymphoma
-
Published:2010-04
Issue:4
Volume:85
Page:280-283
-
ISSN:0361-8609
-
Container-title:American Journal of Hematology
-
language:en
-
Short-container-title:Am. J. Hematol.
Author:
Habermann Thomas M.
Reference29 articles.
1. Clinical cancer advances 2009: Mayor research advances in cancer treatment, prevention, and screening-A report from the American Society of Clinical Oncology;Petrille;J Clin Oncol,2009
2. CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma;Marcus;Blood,2005
3. Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: Results of a prospective randomized study of the German Low-Grade Lymphoma Study Group;Hiddeman;Blood,2005
4. Rituximab to first-line mitoxantrone, chlorambucil, and prednisolone chemotherapy followed by interferon maintenance prolongs survival in patients with advanced follicular lymphoma: An east German study group hematology and oncology study;Herold;J Clin Oncol,2007
5. Rituximab combined with chemotherapy and interferon in follicular lymphoma patients: Results of the GELA-GOELAMS FL2000 study;Salles;Blood,2008